Hemangiopericytoma: A case report

Year 2008, Volume: 23 Issue: 1, 20 - 25, 01.02.2008

Ali Özcan Binatlı Erel Uluğ İlker Özhan Deniz Altınel Ümit Bayol Nurcan Özdamar

Abstract

Hemangiopericytoma is an uncommon neoplasm in central nervous system (CNS). Recently, it has been named under the classification of the spesific tumors of CNS in the meningioma family as the angioblastic variant by WHO in the years of 1997 and 2000. Surgery is very important for the successful treatment of these patients. Radiotherapy (RT) is helpful in the management after the operation. Because hemangiopericytomas are extremely difficult to cure surgicaly, patients should receive postoperative RT regardless of the amount of tumor resected. Guthrie et al. emphasized particularly the importance of complete tumor removal at the first operation and subsequent RT to prolong the survival period. In our case, 54- year-old male patient with Hemangiopericytoma was operated. The tumour has been totally resected and RT has been applied after the operation as it is mentioned above. The follow- up has been occuring sufficiently in our clinic.

Keywords

Middle Aged, Male, Hemangiopericytoma, Neoplasms, Vascular Tissue, Magnetic Resonance Imaging, Vimentin, Radiotherapy, Treatment Outcome

Hemanjiyoperisitoma: Olgu sunumu

Abstract

Santral sinir sistemi (SSS) hemanjiyoperisitoması nadir görülür. Son zamanlarda bu tümör, SSS'nin spesifik tümörleri içine dahil edilmiştir. Dünya Sağlık Örgütü'nün 1997 ve 2000 yıllarındaki sınıflandırmasında meningiom ailesi içine ve bu ailenin içinde de anjiyoblas tik varyant içine dahil edilmiştir. En etkin tedavisi tümörün total rezeksiyonu ve sonrasında da radyoterapidir (RT). Hemanjiyoperisitomanın cerrahi kürü oldukça zor olduğu için, rezeke edilen tümör miktarına bakmaksızın hastalar ameliyat sonrası RT tedavisi almalıdırlar. Guthrie ve ark. ilk operasyonda total tümör çıkarımının ve sonrasında da RT'nin önemini, hayatta kalma süresini uzatmak açısından özellikle vurgulamışlardır. Bu yazıda sunulan 54 yaşındaki erkek hastamızda tümör total rezeke edildi ve sonrasında RT için sevki yapıldı. Hastanın takibi halen tarafımızca yapılmaktadır.

Keywords

Hemanjiyoperisitoma, meningeal tümörler, radyoterapi, vimentin/analiz.

References

• 1. Stout AP, Murray MR. Hemangiopericytoma: a vascular tu-mor featuring Zimmerman’s pericytes. Ann Surg 1942;116(1):26-33.
• 2. Ater JL, Rytting M. Rare malignant brain tumors. In: Black PM, Loeffler JS, edi t o rs. Cancer of the ne r v o u s system. Cambridge: Blackwell Science; 1 9 9 7. p. 6 2 0 - 2 .
• 3. Guthrie BL, Ebersold MJ, Scheithauer BW, Shaw EG. Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery 1989;25(4):514-22.
• 4. Jääskeläinen J, Servo A, Haltia M, Wahlström T, Valtonen S. Intracranial hemangiopericytoma: radiology, surgery, radiotherapy, and outcome in 21 patients. Surg Neurol 1985;23(3):227-36.
• 5. Begg CF, Garret R. Hemangiopericytoma occurring in the meninges: case report. Cancer 1954;7(3):602-6.
• 6. Berger MS, Kros JM. Sarcomas and neoplasms of blood ves-sels. In: Youmans JR, Becker DP, Dunsker SB, edi t o rs. Neurological su rg e r y. 4th ed. Philadelphia: Saunders WB; 1996. p. 2700-3.
• 7. Plukker JT, Koops HS, Molenaar I, Vermey A, ten Kate LP, Oldhoff J. Malignant hemangiopericytoma in three kindred members of one family. Cancer 1988;61(4):841-4.
• 8. Mena H, Ribas JL, Pezeshkpour GH, Cowan DN, Parisi JE. Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol 1991;22(1):84-91.
• 9. Alén JF, Lobato RD, Gómez PA, Boto GR, Lagares A, Ramos A, et al. Intracranial hemangiopericytoma: study of 12 cases. Acta Neurochir (Wi e n ) 2001;143(6):575-86.
• 10. Galanis E, Buckner JC, Scheithauer BW, Kimmel DW, Schomberg PJ, Piepgras DG. Management of recurrent meningeal hemangiopericytoma. Cancer 1998;82(10):1915-20.
• 11. Dufour H, Métellus P, Fuentes S, Murracciole X, Régis J, Figarella-Branger D, et al. Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. Neurosurgery 2001;48(4):756-63.
• 12. Enzinger FM, Smith BH. Hemangiopericytoma. An analysis of 106 cases. Hum Pathol 1976;7(1):61-82.
• 13. Seibert JJ, Seibert RW, Weisenburger DS, Allsbrook W. Multiple congenital hemangiopericytomas of the head and neck. Laryngoscope 1978;88(6):1006-12.
• 14. Kuhn C 3rd, Rosai J. Tumors arising from pericytes. Ultrastructure and organ culture of a case. Arch Pathol 1969;88(6):653-63.
• 15. Horten BC, Urich H, Rubinstein LJ, Montague SR. The angioblastic meningioma: a reappraisal of the nosological problem. Light-, electron-microscopic, tissue, and organ culture observations. J Neurol Sci 1977;31(3):387-410.
• 16. Stout AP. Tumors of the soft tissues. Atlas of tumor pathology. section 2, fascicle 5. Washington, DC: Armed Forces Institute of Pathology; 1953. p. 99-103.
• 17. D’Amore ES, Manivel JC, Sung JH. Soft-tissue and meningeal hemangiopericytomas: an immunohistochemical and ultrastructural study. Hum Pathol 1990;21(4):414-23.
• 18. Kleihues P, Cavenee WK, eds. WHO classification of tumours of the central nervous system pathology and genetics of tumors of central nervous system. Lyon: International Agency for Research of Cancer; 2000. p. 6-7.
• 19. Kleihues P, Burger PC, Scheithauer BW. Tumours of the meninges in histological typing of tumours of the central nervous system, 2nd. ed. Berlin: SpringerVerlag; 1993. p. 33-8.
• 20. Ebersold MJ, Quasi LM. Men in geal hemangiopericytomas. In: Wilkins RH, Rengachary SS, editors. N e u r o s u rg e r y. 2nd ed. New Yo r k: M c G r a w - H i l l; 1996. p. 1733-9.
• 21. Marc JA, Takei Y, Schechter MM, Hoffman JC. Intracranial hemangiopericytomas. A n g i o g r a p h y, pathology and differential diagnosis. Am J Roentgenol Radium Ther Nucl Med 1975;125(4):823-32.
• 22.Chaubal A, Paetau A, Zoltick P, Miettinen M. CD34 immunoreactivity in nervous system tumors. Acta Neuropathol 1994;88(5):454-8.
• 23.Cohen PR, Rapini RP, Farhood AI. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors. J Cutan Pathol 1993;20(1):15-20.
• 24. Yu CC, Hall PA, Fletcher CD, Camplejohn RS, Waseem NH, Lane DP, et al. Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology 1991;19(1):29-3.
• 25. Vuorinen V, Sallinen P, Haapasalo H, Visakorpi T, Kallio M, Jääskeläinen J. Outcome of 31 intracranial haemangiopericytomas: poor predictive value of cell proliferation indices. Acta Neurochir (Wi e n ) 1996;138(12):1399-408.
• 26.Bastin KT, Mehta MP. Meningeal hemangiopericytoma: defining the role for radiation therapy. J Neurooncol 1992;14(3):277-87.
• 27. Lackner H, Urban C, Dornbusch HJ, Schwinger W, Kerbl R, Sovinz P. Interferon alfa-2a in recurrent metastatic hemangiopericytoma. Med Pediatr Oncol 2003;40(3):192-4.
• 28. Kirn DH, Kramer A. Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytoma. J Natl Cancer Inst 1996;88(11):764-5.
• 29. Sheehan J, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for treatment of recurrent intracranial hemangiopericytomas. Neurosurgery 2002;51(4):905- 11.
• 30. Koyama H, Harada A, Nakao A, Nonami T, Kurokawa T, Kaneko T, et al. Intracranial hemangiopericytoma with metastasis to the pancreas. Case report and literature review. J Clin Gastroenterol 1997;25(4):706-8.
• 31. Suzuki H, Haga Y, Oguro K, Shinoda S, Masuzawa T, Kanai N. Intracranial hemangiopericytoma with extracranial metastasis occurring after 22 years. Neurol Med Chir (Tokyo) 2002;42(7):297-300.